TrialBritish journal of cancer2010

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.

T Conroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.